Mononuclear phagocytes are classified as macrophages or dendritic cells (DCs) based on cell morphology, phenotype, or select functional properties. However, these attributes are not absolute and often overlap, leading to difficulties in cell-type identification. To circumvent this issue, we describe a mouse model to define DCs based on their ontogenetic descendence from a committed precursor. We show that precursors of mouse conventional DCs, but not other leukocytes, are marked by expression of DNGR-1. Genetic tracing of DNGR-1 expression history specifically marks cells traditionally ascribed to the DC lineage, and this restriction is maintained after inflammation. Notably, in some tissues, cells previously thought to be monocytes/ macrophages are in fact descendants from DC precursors. These studies provide an in vivo model for fate mapping of DCs, distinguishing them from other leukocyte lineages, and thus help to unravel the functional complexity of the mononuclear phagocyte system.
SUMMARY
Mononuclear phagocytes are classified as macrophages or dendritic cells (DCs) based on cell morphology, phenotype, or select functional properties. However, these attributes are not absolute and often overlap, leading to difficulties in cell-type identification. To circumvent this issue, we describe a mouse model to define DCs based on their ontogenetic descendence from a committed precursor. We show that precursors of mouse conventional DCs, but not other leukocytes, are marked by expression of DNGR-1. Genetic tracing of DNGR-1 expression history specifically marks cells traditionally ascribed to the DC lineage, and this restriction is maintained after inflammation. Notably, in some tissues, cells previously thought to be monocytes/ macrophages are in fact descendants from DC precursors. These studies provide an in vivo model for fate mapping of DCs, distinguishing them from other leukocyte lineages, and thus help to unravel the functional complexity of the mononuclear phagocyte system.
INTRODUCTION
Dendritic cells (DCs) play a key role in immune regulation. Historically, DCs have been identified as nonlymphocytic motile cells of dendritic morphology, expressing high levels of major histocompatibility complex class II molecules (MHCII) and the integrin CD11c (Geissmann et al., 2010; Hashimoto et al., 2011; Heath and Carbone, 2009; Steinman and Idoyaga, 2010) . In addition, functional criteria, including migratory capacity and superior ability to stimulate T lymphocytes, are often used to distinguish DCs from other mononuclear phagocytes such as macrophages (MØs) and monocytes (Hashimoto et al., 2011; Milling et al., 2010; Steinman and Idoyaga, 2010) . However, functional attributes are not discrete cellular properties, and phenotypic markers are often shared among related cell types, particularly after infection or during inflammation when they are up-and downregulated. The inability to accurately distinguish DCs and MØs has led to confusion and debate and makes it difficult to assess whether individual mononuclear phagocyte subtypes have unique functions in the immune system (Hashimoto et al., 2011; Hume, 2008) .
Gene expression analysis and ontogenetic relationships have been used to refine the definition of DCs and MØs. For instance, two types of MØs and two subsets of DCs have been described across lymphoid and nonlymphoid tissues of both mice and humans by comparing gene expression signatures and/or demonstrating that the development of a given population depends on a specific transcription factor, cytokine, or growth factor Geissmann et al., 2010; Greter et al., 2012; Haniffa et al., 2012; Hashimoto et al., 2011; Heath and Carbone, 2009; Hildner et al., 2008; Meredith et al., 2012a; Miller et al., 2012; Persson et al., 2013; Satpathy et al., 2012; Satpathy et al., 2011; Schlitzer et al., 2013; Schulz et al., 2012; Tussiwand et al., 2012) . Nevertheless, there remains the need for an overarching ontogenetic definition that unifies the DC family and establishes it as an independent leukocyte lineage (Hashimoto et al., 2011) .
Mouse bone marrow (BM) cells lacking lineage-restricted markers (lin) and expressing CD115 (M-CSF receptor), CD135 (fms-like tyrosine kinase receptor-3), CX 3 CR1, and low levels of CD117 (c-kit, stem cell factor receptor) give rise only to DCs after in vitro culture or transfer into mice and are termed common DC precursors (CDPs) (Auffray et al., 2009; Liu et al., 2009; Naik et al., 2007; Onai et al., 2007) . CDPs do not exit the BM but give rise to pre-DCs, which migrate through the blood to lymphoid and nonlymphoid organs, where they terminally differentiate into conventional DCs (cDCs), including the two main CD11b + and CD11b -cDC subsets Liu et al., 2009; Naik et al., 2006 Naik et al., , 2007 Onai et al., 2007) . In contrast, plasmacytoid DCs (pDCs) are thought to derive from CDPs independently of pre-DCs Naik et al., 2007; Onai et al., 2007) , although their CDP origin has recently been questioned (Onai et al., 2013) . As ontogeny is immutable, the tracking of CDP and pre-DC progeny should allow for definition of the DC lineage irrespective of markers or functional criteria. This would help resolve issues of nomenclature within the mononuclear phagocyte family and provide a system for studying DC dynamics in the steady state and after inflammation or infection. Here, we report that precursors of cDC can be defined in mice by expression of the C-type lectin receptor DNGR-1 and describe a model for genetic labeling of DNGR-1-expressing cells and their progeny that allows for ontogenetic definition of the DC lineage in mice.
RESULTS
DNGR-1 Marks CDP and Pre-DC DNGR-1 (also known as CLEC9A) is expressed at high levels by CD8a + and CD103
+ CD11b
À cDCs and at lower levels by pDCs in mice (Caminschi et al., 2008; Poulin et al., 2012; Sancho et al., 2008) . We additionally noticed the presence of low levels of the receptor on splenic pre-DCs, defined as lin À CD11c + CD43 + CD135 + CD172a low cells (Naik et al., 2006) , from wild-type, but not control DNGR-1-deficient (Clec9a gfp/gfp ) mice (Sancho et al., 2009 ; Figure S1A available online). Pre-DCs from BM also expressed DNGR-1 ( Figure S1B ). In that organ, DNGR-1 + cells were additionally found in the lin
+ compartment, which includes MØ/DC precursors (MDPs; Fogg et al., 2006) and CDPs ( Figure 1A ). However, DNGR-1 expression correlated with lower levels of CD117 ( Figure 1A ), a phenotype associated with CDP activity in transfer studies (Auffray et al., 2009; Naik et al., 2007; Onai et al., 2007 Figure 1C ), but expressed low levels of F4/80 and CD11b ( Figure 1C ), suggesting that they might constitute pre-DCs (Naik et al., 2006 See Figure S1 . No YFP labeling of erythrocytes or nonhematopoietic cells was observed (data not shown).
We next assessed the presence and penetrance of the YFP signal in spleen DC subpopulations. We found that 99.1% ± 0.4% of CD8a + cDCs were YFP + ( Figures 3A and 3B ). This high labeling efficiency is to be expected from additive effects of Cre activity in DC precursors and in differentiated CD8a + cDCs, which express high levels of DNGR-1 (Caminschi et al., 2008; Sancho et al., 2009 ). CD11b + cDCs lack DNGR-1 protein or messenger RNA (mRNA) (Caminschi et al., 2008; Sancho et al., 2009) S3C ), suggesting that both can be generated from CDP in the steady state despite earlier suggestions to the contrary (Lewis et al., 2011) . Interestingly, pDCs showed a much lower degree of YFP labeling (20.6% ± 7.4%) than CD11b + cDCs (Figures 3A and 3B) even though they express low levels of DNGR-1 (Sancho et al., 2008) . This is consistent with our transfer data indicating that pDCs do not descend from DNGR-1 + precursors (see Figures 1C and 1E ) and, therefore, do not have the opportunity to excise the stop codon preceding YFP during development. A DC that lacks CD205 expression but expresses CD8a and CX 3 CR1 and resembles pDCs has recently been identified (Bar-On et al., 2010; Edelson et al., 2010) . Interestingly, 78% ± 5% of these CD8a
were labeled with YFP ( Figures 3A and 3B ) even though they express DNGR-1 at levels comparable to classical pDCs (data not shown; Figure 3A ). This high degree of YFP labeling suggests that some CD8a + CD205 À pDCs may arise from CDP (see Discussion). YFP + cells were located in the T cell areas of the white pulp, as well as scattered around the red pulp, mimicking the known distribution of DCs in steady state ( Figure 3C ). Importantly, no YFP signal was observed in CD169 + metallophilic MØs ( Figure 3C ) or in blood Ly-6C hi and Ly-6C low monocytes, which arise from MDP and can act as precursors of tissue MØs ( Figure S3A ). We obtained analogous results when analyzing YFP expression in CD11c + MHCII + resident cDCs in skin-draining lymph nodes (sdLN; Figures 3D and 3E ). In sdLN, we also examined YFP labeling among the CD11c + MHCII hi migratory DCs ( Figures   3D and 3E ). CD103 + migratory cDCs displayed extensive YFP labeling (91.5% ± 1.4%; Figures 3D and 3E) , which is in line with the fact that they express high levels of DNGR-1 (Poulin et al., 2012) . CD103
+ cells lack DNGR-1 expression (Poulin et al., 2012) but also labeled with YFP (41.2% ± 5%; Figures 3D and 3E ), confirming their CDP origin . Importantly, CD103 À CD207 + Langerhans cells (LCs), which predominantly arise from embryonic precursors (Chorro et al., 2009; Hoeffel et al., 2012) , showed little YFP expression (2.7% ± 1.1%; Figures 3D and 3E ). We obtained equivalent results in spleen and sdLN of Rosa26-stop flox -YFP mice crossed to Clec9a-Cre mice generated using a bacterial artificial chromosome (BAC) transgenic approach ( Figures S3D-S3F ). In sum, tracing the expression history of DNGR-1 reveals CDP-derived populations in lymphoid organs and confirms the cDC-restricted potential of DNGR-1 + precursors. Figure 4A ). To assess labeling of pulmonary DCs, we gated on CD11c + MHCII + cells ( Figure 4C) after excluding CD11c hi autofluorescent alveolar MØs, which are YFP negative ( Figure 4B ). Within this gate, CD64 + CD11b + cells ( Figure 4C ) have been argued to represent monocyte progeny Langlet et al., 2012; Plantinga et al., 2013; Tamoutounour et al., 2012 Figures 4C and 4D) , which express DNGR-1 (Desch et al., 2011; Poulin et al., 2012) , and a lower degree of labeling of CD103 À CD11b À and CD11b + cells (52% ± 8.4% and 27.6% ± 2.6%, respectively; Figures 4C and 4D) , which lack DNGR-1 expression (Poulin et al., 2012) . As in lymphoid organs, pDCs were inefficiently labeled (10.3% ± 3.3%, Figure 4D ), despite expressing DNGR-1 at low levels. We obtained analogous lineage-tracing results in lungs from Clec9a-Cre BAC mice (Figure S4A) . In either mouse model, we found no YFP labeling of eosinophils, neutrophils, alveolar MØs, or Ly-6C hi monocytes
( Figures 4D and S4A) . In small intestine, CD11c + MHCII + cells include CD64 + cells marked by intermediate to low levels of CD11c ( Figure 4E ) and high levels of CD11b (data not shown). These cells likely correspond to monocyte-derived CD11c low CX 3 CR1 + cells Tamoutounour et al., 2012; Varol et al., 2009) Figure 4E ), as described 
À cDCs express DNGR-1 ( Figure S4B and S4C) and labeled extensively with YFP (96% ± 0.8%; Figures 4E and 4F ). CD11b + cells lack DNGR-1 protein and mRNA ( Figure S4B and S4C) but labeled strongly with YFP irrespective of CD103 expression ( Figures 4E and 4F Figure S3 . Figures 6D and 6E) . B cells were inactive in the same assay, whereas splenic CD11b + cDCs were the most potent APC (Figures 6D and 6E ). Both kidney YFP + CD64 + cells and spleen CD11b + cDCs supported the differentiation of T lymphocytes into effector cells producing interferon-g (IFN-g) and tumor necrosis factor-a (TNF-a; Figure 6F) (Geissmann et al., 2010; Hashimoto et al., 2011; Heath and Carbone, 2009; Steinman and Idoyaga, 2010 [Serbina et al., 2003b] ) could be identified as Gr-1 + CD11b low that produce TNF-a ( Figure 7A ). Importantly, these TipDCs did not label with YFP ( Figure 7A ), which is in contrast to CD11c + Gr-1 À cDCs ( Figure 7B ). It has been shown that monocytes can differentiate into migratory APCs capable of priming naive T cells in models of colitis Zigmond et al., 2012) . We therefore analyzed cellular infiltrates in the colon of Clec9a +/cre Rosa +/EYFP mice after 5 days of oral DSS treatment. In colitic colon, DNGR-1 expression remained restricted to CD103 + CD11b À DCs (Figure 7C) . We identified monocyte-derived cells as CD11b + nonneutrophils expressing either Gr-1 or CD64. As reported , they encompassed three populations with varying expression levels of MHCII and Gr-1 ( Figure 7D ; ''Mo-waterfall'' gate). Importantly, none of these monocyte-derived populations expressed significant levels of YFP ( Figure 7D ), which is in contrast to CD11c + MHCII + CD64
À cDCs ( Figure 7E ). Thus, Clec9a +/cre Rosa +/EYFP mice specifically trace CDP, but not monocyte progeny during systemic bacterial infection or acute intestinal inflammation.
DISCUSSION
The classification of mononuclear phagocytes as DCs or MØs is largely based on phenotypic and/or functional criteria. This has led to substantial confusion (Hume, 2008) , especially during infection or inflammation when many of the supposedly defining markers and functions of DCs change profoundly (Geissmann et al., 2010; Hashimoto et al., 2011; Heath and Carbone, 2009 ). The identification of more restricted DC markers has thus far not offered a conclusive resolution to cell type definition. For instance, expression of Zbtb46, which distinguishes cDCs from other lymphoid and myeloid cells, is downregulated after DC stimulation and is additionally found on endothelial cells, early erythroid progenitors, and monocytes stimulated with GM-CSF + IL-4 (Meredith et al., 2012a (Meredith et al., , 2012b Satpathy et al., 2012) . To circumvent the limitations of an approach based purely on phenotype and function, here we adopt an ontogenetic perspective to define cDCs. We show that DNGR-1 acts as a bona fide marker of mouse cDC precursors and describe a model in which cDCs can be faithfully identified by means of their DNGR-1 expression history. Clec9a +/cre Rosa +/EYFP mice thus provide a genetic model with which to assess the contribution of a committed myeloid precursor to the mononuclear phagocyte system and can be used to define the mouse DC lineage from its first committed precursor through to the differentiated state. DNGR-1 + precursors did not give rise to pDCs in adoptive transfer or genetic labeling experiments, which is consistent with recent suggestions that pDCs arise from a distinct pDC-specific precursor (Cisse et al., 2008; Onai et al., 2013; Satpathy et al., 2012) . Such results put in question the existence of a ''common DC precursor'' that gives rise to cDCs and pDCs, but not monocytes. For simplicity, we continue to refer to the DNGR-1 + precursor as ''CDP,'' although we use this acronym to mean ''conventional DC precursor.'' Intriguingly, CD8a
although resembling classical pDCs (Bar-On et al., 2010), were highly labeled with YFP in our reporter mice. Thus, some CD8a + CD205 À pDCs may arise from CDP, although refined lineage tracing systems, such as a Clec9a-driven inducible Cre recombinase, will be needed to fully resolve the issue. Nevertheless, our genetic mapping analysis suggests that similarities in gene expression and transcription factor dependence do not always allow accurate conclusions about cell ontogeny. Our analysis reveals the presence of CDP-derived cells among the intestinal CD11b + CD103 À mononuclear phagocyte pool, which has previously been suggested to arise from monocytes Varol et al., 2009) . As those earlier studies did not include the CD64 marker in their analysis, it is conceivable that the monocyte contribution is limited to CD103 À CD11b + cells that express CD64, which likely correspond to CX 3 CR1 hi MØs (Varol et al., 2009) . Our fate mapping analysis also reveals the existence of CDP-derived cells within the renal mononuclear CD64 + phagocyte pool. This indicates that CD64 expression does not always mark monocyte progeny and is in line with the emerging concept that mononuclear phagocytes with apparently overlapping phenotype can have distinct origins (Hashimoto et al., 2013; Hoeffel et al., 2012; Schulz et al., 2012) . Conversely, our analysis also reveals the presence of cells with distinct phenotypes but common origin such as the ESAM hi and ESAM low spleen cDC populations. Altogether, these observations raise the question of the extent to which nature versus nurture dictates the functions of mononuclear phagocytes. Consistent with a dominant role for nature, YFP + CD64 + kidney cells have morphological, phenotypic, and functional characteristics of cDCs. However, in other circumstances, CDP-derived cells might be poor stimulators of T cells or lack other typical features of DCs. The ability to define DCs on the basis of ontogeny allows for investigation of typical and atypical DC functions and will help to determine the extent to which functions of mononuclear phagocytes are dictated by environmental imprinting.
Due to the incomplete penetrance of labeling, conclusions cannot be drawn about the lack of YFP in any given cell and, instead, YFP needs to be considered at the level of cell populations. We believe the origins of the incomplete labeling lie in the nature of the system rather than in DC heterogeneity. Because of a time lag between Cre protein synthesis and DNA recombination, actively dividing DC precursors Onai et al., 2007) can dilute Cre protein before excising the floxed stop cassette. This causes a fraction of the precursors to ''escape'' labeling in a stochastic fashion, as seen in other fate mapping models (Jakubzick et al., 2008; Ye et al., 2003; Yona et al., 2013) . Confirming that notion, increased Cre expression (in homozygous Clec9a-Cre mice) leads to markedly increased labeling of DC precursors and near-complete marking of differentiated cDCs ( Figure S7 ). These data confirm that Clec9a +/cre Rosa +/EYFP mice allow for the identification of CDP-derived populations based on YFP labeling frequencies. The one exception is pDCs, which express low levels of DNGR-1 and in which the presence of YFP is not necessarily an indicator of ontogeny but of receptor expression. Should other cell types upregulate DNGR-1 in specific circumstances, a similar caveat would apply. In such ambiguous cases, YFP analysis may require further refinement, such as the concomitant adoptive transfers presented here. As shown here, Clec9a +/cre Rosa +/EYFP mice will be especially useful for tracing CDP-derived cells during infection and inflammation. Clec9a-Cre mice may also be used to manipulate gene expression specifically in CDP-derived cells, opening perspectives with regards to understanding the functional complexity of the mononuclear phagocyte system. Finally, our data confirm the notion of cDCs as an independent hematopoietic lineage (Naik et al., 2013) and pave the way toward a revised nomenclature of mononuclear phagocytes that takes cell ancestry into account.
EXPERIMENTAL PROCEDURES Mice

Clec9a
+/cre , Clec9a gfp/gfp , Rosa26-stop flox -EYFP (Srinivas et al., 2001 ), Rosa26-stop flox -tdRFP (Luche et al., 2007) , C57BL/6J, and B6.SJL mice were bred at Cancer Research UK in specific pathogen-free conditions. 6-to 10-week-old littermate control mice were used. Animal experiments were performed in accordance with national and institutional guidelines for animal care and approved by the London Research Institute Animal Ethics Committee and by the UK Home Office.
Isolation of Cells
All lymphoid and nonlymphoid tissues, except bone marrow, were subjected to enzymatic digestion with Collagenase IV (200 U/ml; Worthington) and DNase I (0.2 mg/ml, Roche) to isolate cells for flow cytometry. Figure S1D ; n = 5) or total BM cells (n = 6) from B6.SJL mice were transferred i.v. into sublethally irradiated CD45.2 recipients. See also Figure S5 . cells) were cultured with APCs (titrated starting at 5 3 10 4 cells) and OVA protein (10 mg/ml) for 4 days (96 well V-bottom plates). CFSE profiles were analyzed by flow cytometry or cells were restimulated with PMA (10 ng/ml) and ionomycin (1 mg/ml) in the presence of Brefeldin A (5 mg/ml) for 4 hr for intracellular cytokine staining. 2.5 3 10 4 BM monocytes were cultured in complete RPMI supplemented with GM-CSF (10 ng/ml; produced at Cancer Research UK) ± IL-4 (20 ng/ml; R&D systems) for 5 days. On day 3, half of the media was replaced with fresh cytokine cocktail.
Image Stream
Samples were acquired on a 4-laser, six channel ISx imaging flow cytometer at 603 magnification and analyzed using IDEAS 5.0 (both IFC, Amnis). At least 1 3 10 5 single cells were collected using a bright-field threshold. A compensation matrix was generated using single-color controls to perform postacquisition spectral correction on a per pixel, per channel basis (Filby and Davies, 2012 [Lauvau et al., 2001 ]) added at a 50:1 ratio of HKLM:splenocytes (Serbina et al., 2003a) .
DSS Colitis
Mice received Dextran Sulfate Sodium Salt (DSS, 2%) in drinking water as described (Wirtz et al., 2007; Zigmond et al., 2012) and were monitored for weight loss every day. On day 5 of DSS treatment, colons were analyzed. 
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